These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32741897)

  • 1. Extraction of peroxisome proliferator-activated receptor α agonist-induced lipid metabolism-related and unrelated genes in rat liver and analysis of their genomic location.
    Mizukawa Y; Amagase Y; Urushidani T
    J Toxicol Sci; 2020; 45(8):449-473. PubMed ID: 32741897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor α agonist-induced histidine decarboxylase gene expression in the rat and mouse liver.
    Amagase Y; Mizukawa Y; Urushidani T
    J Toxicol Sci; 2020; 45(8):475-492. PubMed ID: 32741898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
    J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators.
    Tamura K; Ono A; Miyagishima T; Nagao T; Urushidani T
    J Toxicol Sci; 2006 Dec; 31(5):471-90. PubMed ID: 17202761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome analyses demonstrate that Peroxisome Proliferator-Activated Receptor α (PPARα) activity of an ultraviolet absorber, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole, as possible mechanism of their toxicity and the gender differences.
    Hirata-Koizumi M; Ise R; Kato H; Matsuyama T; Nishimaki-Mogami T; Takahashi M; Ono A; Ema M; Hirose A
    J Toxicol Sci; 2016; 41(5):693-700. PubMed ID: 27665778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
    Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
    Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PPARα agonists fenofibrate and CP-778875 cause increased β-oxidation, leading to oxidative injury in skeletal and cardiac muscle in the rat.
    Pettersen JC; Pruimboom-Brees I; Francone OL; Amacher DE; Boldt SE; Kerlin RL; Ballinger WE
    Toxicol Pathol; 2012 Apr; 40(3):435-47. PubMed ID: 22301950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARα-mediated responses in human adult liver stem cells: In vivo/in vitro and cross-species comparisons.
    Kim S; Kiyosawa N; Burgoon LD; Chang CC; Zacharewski TR
    J Steroid Biochem Mol Biol; 2013 Nov; 138():236-47. PubMed ID: 23811191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
    Yamazaki K; Kuromitsu J; Tanaka I
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.
    Gonzalez FJ; Shah YM
    Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists.
    Frederiksen KS; Wulf EM; Wassermann K; Sauerberg P; Fleckner J
    J Mol Endocrinol; 2003 Jun; 30(3):317-29. PubMed ID: 12790802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists down-regulate alpha2-macroglobulin expression by a PPARalpha-dependent mechanism.
    González MC; Corton JC; Cattley RC; Herrera E; Bocos C
    Biochimie; 2009 Aug; 91(8):1029-35. PubMed ID: 19497347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
    Cwinn MA; Jones SP; Kennedy SW
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):165-71. PubMed ID: 18565798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice.
    Ernst MC; Sinal CJ; Pollak PT
    Pharmacol Res; 2010 Nov; 62(5):408-15. PubMed ID: 20654716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.